Predoctoral Fellowship

Develop your skills ahead of your PhD application

Alloy’s Predoctoral Fellowship is a paid training program designed to enable the next generation of biotechnology leaders to gain two years of industry experience before transitioning into a top-tier PhD program. The Fellowship is a unique, 24 month experience where you will develop your knowledge and lab skills as you apply for and prepare to start your PhD training in a top-tier graduate program. While you work in the lab, Alloy supports your application process and connects you with our extensive network of collaborators and academic labs. In addition, we offer Predoc Fellows $50,000 in tuition and living reimbursement if they return to Alloy after completion of their PhD program.

Our Predoc Fellows will have the unique opportunity to be immersed in Alloy’s collaborative biotechnology ecosystem and will work side by side with a passionate team of scientists and engineers across our 5 research sites in 3 different countries. Each Predoc will work on developing cutting edge platform technology in one our 6 modalities (Antibodies/Bispecific Antibodies, TCR/TCRm, Genetic Medicines, Cell Therapy, Peptides, and Drug Delivery). Additionally, each Predoc will work to discover new medicines using Alloy’s proprietary technologies in collaboration with our external partners and Venture Studio companies. The Predoc Fellows will play a hands-on role in contributing to our mission to make better medicine, together.

Apply for a Predoc Position

Predoc Fellow, Antibody Discovery

Predoc Fellow, Protein Engineering

Predoc Fellow, protein Sciences & Manufacturing

Follow Alloy on LinkedIn

Targeting GPCRs with Alloy Antibody Discovery Services

Access the white paper

Thanks for your interest in our white paper, Targeting GPCRs with DeepImmune Antibody Discovery.

G protein-coupled receptors (GPCRs) play a central role in multiple physiological functions, from endocrine sensing to neurotransmission to chemotaxis of immune cells. This class has long been an attractive target for novel antibody drug discovery campaigns in multiple disease indications, but their unique nature produces many challenges for in vivo antibody discovery. In this white paper, we detail how our humanized mouse discovery platform, the ATX-Gx™, have been successfully utilized for GPCR-targeted antibody discovery, Alloy Antibody Discovery’s DeepImmune™ module builds on this robust in vivo discovery platform, coupling best-in-class immunogen production with multiple binder recovery approaches, and advanced machine-learning-based techniques for lead identification and optimization.

Keyway TCR Mimic Discovery Webinar

Access the webinar recording

I’d like more material about Keyway TCR Discovery

Thanks for your interest in our recent Keyway TCRm Discovery webinar, Increasing Target Specificity and Tackling Intracellular Targets for TCRm Therapeutics Development with Keyway’s TCRm Discovery Offering. In it, the team at the helm of our TCR mimic discovery campaigns shared:

1. An overview of common challenges to intracellular protein-targeting drug discovery
2. Keyway’s industry-leading solutions to TCRm/TCR-based therapeutic discovery including its proprietary specificity screening and high-quality pMHC complex antigen production capabilities
3. A case study featuring the discovery of a panel of highly specific, functional TCRm binders against an intracellular immuno-oncology target

Upon filling out this form, you will receive an email with a link to the webinar recording.